Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HPGDS | O60760 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38654920 | 0.94 | FUT8 (0.35) | FUT8ALDH1A1CYP1A2HPGDS | |
| SCHEMBL12974319 | 0.91 | FUT8 (0.33) | FUT8 | |
| SCHEMBL12173082 | 0.90 | FUT8 (0.38) | FUT8HPGDS | |
| SCHEMBL12646575 | 0.90 | FUT8 (0.38) | FUT8HPGDS | |
| SCHEMBL14367149 | 0.89 | FUT8 (0.33) | FUT8 | |
| SCHEMBL16373350 | 0.88 | CARM1 (0.35) | FUT8ALDH1A1CYP1A2HPGDS | |
| SCHEMBL20390575 | 0.88 | FUT8 (0.40) | FUT8ALDH1A1CYP1A2HPGDS | |
| SCHEMBL14495144 | 0.86 | FUT8 (0.35) | FUT8HPGDS | |
| SCHEMBL12646672 | 0.85 | POLB (0.31) | — | |
| SCHEMBL29404819 | 0.85 | CARM1 (0.35) | FUT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3173826-A1 | HYDROGEL COMPOSITION AND HYDROGEL CONTACT LENSES MADE OF THE COMPOSITION | Pegavision Corporation (TW) | 2017-05-31 | — | — | EP | disclosed |
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | KRT18, KLK3, KLKB1 | FUT8 2015/4885ALDH1A1 2661/4885CYP1A2 4054/4885 |
| US-20120229884-A1 | CHARGED PARTICLES | POLE3, POLD3, IPO4 | FUT8 769/4885ALDH1A1 3160/4885CYP1A2 4304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.